Product Information
RECTIV 0.4% OINTMENT is a brand product labeled by Allergan, Inc., priced at $20.5857 per GM under NDC 58914030180. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 21, 2011.
Strength
4 mg/g
Manufacturer
Allergan, Inc.NDC
58914030180
Classification
Brand
Dosage Form
OINTMENT
Route
RECTAL
Effective Date
9/23/2026
Active Ingredients
NITROGLYCERINApproval Type
New Drug (NDA)
FDA Application
NDA021359FDA Approved
6/21/2011
On Market Since
6/21/2011
Pharmacological Classes
Price Statistics
The NADAC for RECTIV 0.4% OINTMENT has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 63.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.5857 per GM |
|---|---|
| All-time high | $20.5899 (Sep 16, 2026) |
| All-time low | $12.5575 (Nov 28, 2013) |
| 52-week high | $20.5899 |
| 52-week low | $20.5016 |
| Median price | $20.4396 |
| Average price | $18.7638 |
| Largest weekly change | +9.5% (Jan 10, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nitroglycerin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrate Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RECTIV 0.4% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for RECTIV 0.4% OINTMENT, manufactured by Allergan, Inc., is $20.5857 per GM (NDC 58914030180), effective Sep 30, 2026.
How has the price of RECTIV 0.4% OINTMENT changed over time?
Over the history we have for it, the NADAC for RECTIV 0.4% OINTMENT has risen 63.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RECTIV 0.4% OINTMENT?
Since Nov 28, 2013, the NADAC for RECTIV 0.4% OINTMENT has ranged from a low of $12.5575 (Nov 28, 2013) to a high of $20.5899 (Sep 16, 2026), with a median of $20.4396 per GM.
Are there cheaper alternatives to RECTIV 0.4% OINTMENT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NITROGLYCERIN 0.4% OINTMENT, is $8.3149 per GM — about 60% below RECTIV 0.4% OINTMENT.
Who manufactures RECTIV 0.4% OINTMENT?
RECTIV 0.4% OINTMENT (NDC 58914030180) is labeled by Allergan, Inc., and CMS classifies it as a brand product.